CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1
Zheng, R; Li, YY; Wang, LR; Fang, XL; Zhang, JQ; He, L; Yang, L; Li, DL; Geng, HQ
Geng, HQ (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Urol, Xinhua Hosp, Sch Med, 1665 KongJiang Rd, Shanghai 200092, Peoples R China.; Li, DL (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Li, DL (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
KIDNEY INTERNATIONAL, 2020; 98 (4): 947